Hims & Hers Launches in Australia With Online Men’s Health and Weight-Loss Care
Hims launches nationwide men’s care in Australia after buying Eucalyptus.
Already have an account? Sign in.
Hims launches nationwide men’s care in Australia after buying Eucalyptus.
The FDA approved Scholar Rock’s Isembyld, the first SMA therapy aimed at muscle wasting in patients already on nerve-targeted treatment.
The Phase III SERENA-4 trial did not meet its primary PFS endpoint in untreated advanced ER-positive, HER2-negative breast cancer, despite a numerical benefit.
Citi added a 90-day upside view on AppLovin with a $600 target, calling Q3 concerns misguided.